Vineet Laboratories Ltd (VINEETLAB) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Veerhealth Care

Guj. Terce Labs.

Vineet Laborator

Sandu Pharma.

ANG Lifesciences

Roopa Industries

Mangalam Drugs

Chandra Bhagat

Mono Pharmacare

Medicamen Organ.

Vilin Bio Med

Why is Vineet Laboratories Ltd ?

Weak Long Term Fundamental Strength with a -230.87% CAGR growth in Operating Profits over the last 5 years

Low ability to service debt as the company has a high Debt to EBITDA ratio of 10.01 times
The company has been able to generate a Return on Equity (avg) of 5.08% signifying low profitability per unit of shareholders funds

The company has declared Negative results for the last 6 consecutive quarters

NET SALES(Latest six months) At Rs 24.86 cr has Grown at -41.94%
PAT(Latest six months) At Rs -0.47 cr has Grown at -41.94%
INVENTORY TURNOVER RATIO(HY) Lowest at 1.01 times

Risky - Negative EBITDA

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -23.37%, its profits have fallen by -306.6%

Reducing Promoter Confidence

Promoters have decreased their stake in the company by -13.37% over the previous quarter and currently hold 15.89% of the company
Promoters decreasing their stake may signify reduced confidence in the future of the business

Underperformed the market in the last 1 year

Even though the market (BSE500) has generated returns of 1.97% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -23.37% returns

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Vineet Laborator for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Vineet Laborator

-23.37%

-0.37

62.79%

Sensex

4.66%

0.40

11.83%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-32.11%

EBIT Growth (5y)

-230.87%

EBIT to Interest (avg)

0.43

Debt to EBITDA (avg)

1.59

Net Debt to Equity (avg)

2.96

Sales to Capital Employed (avg)

1.93

Tax Ratio

4.25%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

-4.76%

ROE (avg)

5.08%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

2.68

EV to EBIT

-5.65

EV to EBITDA

-6.88

EV to Capital Employed

1.42

EV to Sales

1.41

PEG Ratio

Dividend Yield

ROCE (Latest)

-25.22%

ROE (Latest)

-117.51%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Bullish

Bearish

Dow Theory

No Trend

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

6What is working for the Company

DEBTORS TURNOVER RATIO(HY)

Highest at 13.17 times

PBDIT(Q)

Highest at Rs 3.18 cr.

OPERATING PROFIT TO NET SALES(Q)

Highest at 18.25%

PBT LESS OI(Q)

Highest at Rs 0.36 cr.

PAT(Q)

Highest at Rs 0.40 cr.

EPS(Q)

Highest at Rs 0.43

-14What is not working for the Company

NET SALES(Latest six months)

At Rs 24.86 cr has Grown at -41.94%

PAT(Latest six months)

At Rs -0.47 cr has Grown at -41.94%

INVENTORY TURNOVER RATIO(HY)

Lowest at 1.01 times

Loading Valuation Snapshot...

Here's what is working for Vineet Laborator

Operating Profit (PBDIT) - Quarterly

Highest at Rs 3.18 cr.

in the last five quarters

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly

Highest at 18.25%

in the last five quarters

MOJO Watch

Company's efficiency has improved

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly

Highest at Rs 0.36 cr.

in the last five quarters

MOJO Watch

Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly

Highest at Rs 0.40 cr.

in the last five quarters

MOJO Watch

Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly

Highest at Rs 0.43

in the last five quarters

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)

Debtors Turnover Ratio- Half Yearly

Highest at 13.17 times

in the last five half yearly periods

MOJO Watch

Company has been able to settle its Debtors faster

Debtors Turnover Ratio

Here's what is not working for Vineet Laborator

Net Sales - Latest six months

At Rs 24.86 cr has Grown at -41.94%

Year on Year (YoY)

MOJO Watch

Near term sales trend is very negative

Net Sales (Rs Cr)

Inventory Turnover Ratio- Half Yearly

Lowest at 1.01 times and Fallen

each half year in the last five half yearly periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio